Circulation:心肌肌钙蛋白与冠状动脉血流储备相关性研究

2014-12-15 MedSci MedSci原创

背景:血清心肌肌钙蛋白(Tn)升高反应了心肌损伤,Tn升高与冠心病死亡率升高相关,甚至没有冠心病的患者Tn升高也与死亡率升高相关。我们探索低水平升高的Tn与减少的冠状动脉血流储备(用于评估冠状动脉血管收缩功能)之间的关联,并评价它们对无明显冠心病患者不良结局的影响。 方法与结果:761例患者,在进行负荷心肌灌注正电子发射断层显像前,通过心肌肌钙蛋白对疑似冠心病进行评估,对主要心血管不良事件进

背景:血清心肌肌钙蛋白(Tn)升高反应了心肌损伤,Tn升高与冠心病死亡率升高相关,甚至没有冠心病的患者Tn升高也与死亡率升高相关。我们探索低水平升高的Tn与减少的冠状动脉血流储备(用于评估冠状动脉血管收缩功能)之间的关联,并评价它们对无明显冠心病患者不良结局的影响。

方法与结果:761例患者,在进行负荷心肌灌注正电子发射断层显像前,通过心肌肌钙蛋白对疑似冠心病进行评估,对主要心血管不良事件进行平均2.8年的随访,包括心血管性死亡,非致命性心肌梗死或晚期血管重建。流量限制型冠心病患者,左心射血分数<40%/60天内进行成像血管重建术患者被排除。静息/负荷心肌血流通过正电子发射断层显像测量冠状动脉血流储备。与Tn-)相比,97Tn+)显示更高的临床预测分数,更多的肾功能不全,以及低左心室射血分数和低冠状动脉血流储备。进行平差分析,冠状动脉血流储备减少和Tn+)独立相关(优势比2.18,95%可信区间1.37-3.47P=0.001),冠状动脉血流储备减少和Tn+)与主要心血管事件独立相关(分别是:危害比2.2595%可信区间1.31-3.86P=0.003;危害比2.42,95%可信区间1.34-4.40P=0.004)。冠状动脉血流储备减少和Tn+)主要心血管事件风险最高(log-rank P<0.0001),两者都与主要心血管事件显著相关(P<0.007)。

结论:无显著冠心病患者,冠状动脉血流储备减少与Tn升高以及主要心血管事件独立相关。冠状动脉血流储备减少显示微血管功能不全,便于改进Tn+)在不良结局中的效果。

原始出处

Taqueti VR, Everett BM, Murthy VL, et al. Interaction of Impaired Coronary Flow Reserve and Cardiomyocyte Injury on Adverse Cardiovascular Outcomes in Patients Without Overt Coronary Artery Disease. Circulation. 2014.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1708949, encodeId=11371e089495d, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Thu Nov 26 10:52:00 CST 2015, time=2015-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837160, encodeId=15f6183e1604f, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Thu Apr 09 20:52:00 CST 2015, time=2015-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2040562, encodeId=7162204056270, content=<a href='/topic/show?id=01223333623' target=_blank style='color:#2F92EE;'>#动脉血流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33336, encryptionId=01223333623, topicName=动脉血流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=869698, createdName=ligang4439, createdTime=Sun Nov 29 06:52:00 CST 2015, time=2015-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490301, encodeId=742a149030115, content=<a href='/topic/show?id=72a651322e0' target=_blank style='color:#2F92EE;'>#心肌肌钙蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51322, encryptionId=72a651322e0, topicName=心肌肌钙蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1de58724110, createdName=wrj0124, createdTime=Wed Dec 17 07:52:00 CST 2014, time=2014-12-17, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1708949, encodeId=11371e089495d, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Thu Nov 26 10:52:00 CST 2015, time=2015-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837160, encodeId=15f6183e1604f, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Thu Apr 09 20:52:00 CST 2015, time=2015-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2040562, encodeId=7162204056270, content=<a href='/topic/show?id=01223333623' target=_blank style='color:#2F92EE;'>#动脉血流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33336, encryptionId=01223333623, topicName=动脉血流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=869698, createdName=ligang4439, createdTime=Sun Nov 29 06:52:00 CST 2015, time=2015-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490301, encodeId=742a149030115, content=<a href='/topic/show?id=72a651322e0' target=_blank style='color:#2F92EE;'>#心肌肌钙蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51322, encryptionId=72a651322e0, topicName=心肌肌钙蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1de58724110, createdName=wrj0124, createdTime=Wed Dec 17 07:52:00 CST 2014, time=2014-12-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1708949, encodeId=11371e089495d, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Thu Nov 26 10:52:00 CST 2015, time=2015-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837160, encodeId=15f6183e1604f, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Thu Apr 09 20:52:00 CST 2015, time=2015-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2040562, encodeId=7162204056270, content=<a href='/topic/show?id=01223333623' target=_blank style='color:#2F92EE;'>#动脉血流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33336, encryptionId=01223333623, topicName=动脉血流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=869698, createdName=ligang4439, createdTime=Sun Nov 29 06:52:00 CST 2015, time=2015-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490301, encodeId=742a149030115, content=<a href='/topic/show?id=72a651322e0' target=_blank style='color:#2F92EE;'>#心肌肌钙蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51322, encryptionId=72a651322e0, topicName=心肌肌钙蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1de58724110, createdName=wrj0124, createdTime=Wed Dec 17 07:52:00 CST 2014, time=2014-12-17, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1708949, encodeId=11371e089495d, content=<a href='/topic/show?id=1502333250f' target=_blank style='color:#2F92EE;'>#动脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33325, encryptionId=1502333250f, topicName=动脉血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048f31575940, createdName=ms9833124466084992, createdTime=Thu Nov 26 10:52:00 CST 2015, time=2015-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837160, encodeId=15f6183e1604f, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Thu Apr 09 20:52:00 CST 2015, time=2015-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2040562, encodeId=7162204056270, content=<a href='/topic/show?id=01223333623' target=_blank style='color:#2F92EE;'>#动脉血流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33336, encryptionId=01223333623, topicName=动脉血流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=869698, createdName=ligang4439, createdTime=Sun Nov 29 06:52:00 CST 2015, time=2015-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490301, encodeId=742a149030115, content=<a href='/topic/show?id=72a651322e0' target=_blank style='color:#2F92EE;'>#心肌肌钙蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51322, encryptionId=72a651322e0, topicName=心肌肌钙蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1de58724110, createdName=wrj0124, createdTime=Wed Dec 17 07:52:00 CST 2014, time=2014-12-17, status=1, ipAttribution=)]

相关资讯

JCEM:桥本氏甲状腺炎患者的冠心病风险更高

甲状腺功能亢进症等甲状腺疾病与心血管疾病的发病相关联,但很少有研究单独探讨自身免疫性疾病和心血管疾病之间的相关性。最近一项研究这项研究旨在发现桥本甲状腺炎和冠心病(CHD)的潜在关联。结果显示,与一般人群相比,桥本氏甲状腺炎患者罹患冠心病的风险更高。这一研究结果发表在内分泌期刊J Clin Endocrinol Metab 10月份在线发表,就来自台湾的研究者发表。既往研究已证实,亚临床甲状腺功能

我国男士冠心病死亡每年增5%,农村成重灾区

积水潭医院丁易教授因心脏病壮年辞世,让人扼腕叹息。实际上,如果我们在百度上搜索“医生”和“猝死”两个关键词,你会发现,因心源性猝死而离世的医生大有人在。究其原因,不外乎是医生生活不规律,累死累活;工作压力大,上厕所都得争分夺秒;睡眠质量差,一辈子做牛做马。Int J Cancer:中国发布最大型癌症生存数据报告 其实不只是医生,我国冠心病死亡形势愈发严峻。阜外心血管病医院刘明波和王文等进

CHC 2014:中国70% 冠心病死亡发生在院前

在中国心脏大会(CHC2014)上,首都医科大学附属北京安贞医院、北京市心肺血管疾病研究所刘静教授从心血管病死亡率、发病率、住院率、院前死亡等几个方面阐述了“中国心血管病流行趋势新动向”。         刘静 教授 她介绍说,在北京进行的一项研究显示,2007~2009 年3 年间,因冠心

ESC 2014:稳定性冠心病 FFR指导PCI优于药物治疗

欧洲心脏病学会(ESC)2014年会公布的一项报告表明,与单纯药物治疗相比,血流储备分数(FFR)指导的经皮冠状动脉介入治疗(PCI)可降低心梗、死亡和血运重建发生率。 FAME-2研究共纳入1220例计划行第二代药物洗脱支架PCI的稳定性冠脉疾病患者,并在随机化之前对所有患者进行FFR测定。至少一处狭窄且FFR≤0.80的患者被随机给予PCI或最佳药物治疗,FFR >0.80的患者则接受

Diabetes care:2型糖尿病患者BMI与冠心病风险正相关性

一项随访7年的研究显示,2型糖尿病患者的基线BMI水平越高,7年后患冠心病(CHD)的风险越高,且女性2型糖尿病患者的BMI水平和冠心病风险或呈U型相关性。该研究发表于Diabetes care杂志。(Diabetes care   2014 Sep 23 ;)来自美国潘宁顿生物医学研究中心( LA Tianjin Women's and Children's Health Center

Diabetes Care:长期使用磺脲类药物可增加冠心病风险

当前,磺脲类药物使用与糖尿病患者心血管疾病风险之间关系的证据不一致。 为此,来自哈佛大学附属布来根女子医院的Frank B. Hu教授及其团队进行了一项研究,评估磺脲类药物使用与心血管疾病风险之间的关系。该研究结果在线发表在2014年08月22日的Diabetes Care杂志上。 该研究中,Hu教授等对4902例基线无心血管疾病的女性糖尿病患者进行随访,患者平均年龄为68岁,平均糖尿病病程为